Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Trial N/A Unknown May 6, 2024

Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)

Trial Phase 1 Unknown May 2, 2024

Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation

Trial N/A Recruiting May 1, 2024

An Automated Navigation System for Deep Brain Electrode Implantation

Trial N/A Unknown May 1, 2024

A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

Trial Phase 1 Completed April 30, 2024

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Trial Phase 2 Completed April 30, 2024

Effect of Virtual Reality on Freezing Phenomenon, Balance, Functional Mobility, Participation in Parkinson's Patients

Trial N/A Unknown April 29, 2024

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

Trial N/A Completed April 29, 2024

A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Trial Phase 1 Completed April 28, 2024

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Trial Phase 1 Unknown April 28, 2024

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Trial N/A Completed April 28, 2024

Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease

Trial N/A Completed April 25, 2024

Virtual Reality and Fear of Falling in Parkinson's Disease

Trial N/A Unknown April 25, 2024

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Trial Phase 3 Completed April 24, 2024

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

Trial Phase 1 Completed April 24, 2024

12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

Trial Phase 2 Completed April 24, 2024

A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients

Trial Phase 2 Completed April 24, 2024

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Trial Phase 3 Completed April 24, 2024

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Trial Phase 3 Completed April 24, 2024

Identification of a Biomarker Predictive of Evolution of Parkinson Disease

Trial Phase 2 Unknown April 24, 2024